Personal tools

Coexpression cluster:C178

From FANTOM5_SSTAR

Revision as of 16:33, 18 May 2012 by Autoedit (talk | contribs) (Created page with "{{Coexpression_clusters |full_id=C178_spleen_liver_Hepatocyte_b_lymph_vein_thymus |id=C178 }}")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.


Full id: C178_spleen_liver_Hepatocyte_b_lymph_vein_thymus



Phase1 CAGE Peaks

Hg19::chr10:102890767..102890780,+p4@TLX1
Hg19::chr10:102891007..102891008,+p9@TLX1
Hg19::chr10:98014908..98014919,-p@chr10:98014908..98014919
-
Hg19::chr10:98014943..98014960,-p@chr10:98014943..98014960
-
Hg19::chr11:1891326..1891337,-p@chr11:1891326..1891337
-
Hg19::chr11:1891472..1891476,+p48@LSP1
Hg19::chr11:1891482..1891489,+p42@LSP1
Hg19::chr11:56859569..56859572,-p@chr11:56859569..56859572
-
Hg19::chr11:56859584..56859589,-p@chr11:56859584..56859589
-
Hg19::chr11:925449..925458,+p17@AP2A2
Hg19::chr12:101869096..101869118,+p1@SPIC
Hg19::chr12:101882023..101882028,+p@chr12:101882023..101882028
+
Hg19::chr12:120168462..120168466,-p@chr12:120168462..120168466
-
Hg19::chr12:57388270..57388282,+p1@GPR182
Hg19::chr12:57388297..57388302,+p3@GPR182
Hg19::chr12:57388350..57388361,+p2@GPR182
Hg19::chr12:72481040..72481051,+p19@TRHDE
Hg19::chr12:72481055..72481060,+p28@TRHDE
Hg19::chr14:24168655..24168686,+p@chr14:24168655..24168686
+
Hg19::chr14:75904485..75904519,+p12@JDP2
Hg19::chr14:81859777..81859783,-p@chr14:81859777..81859783
-
Hg19::chr15:94899297..94899314,+p16@MCTP2
Hg19::chr16:31404650..31404662,+p1@ITGAD
Hg19::chr17:72313080..72313103,-p@chr17:72313080..72313103
-
Hg19::chr17:72313399..72313408,-p@chr17:72313399..72313408
-
Hg19::chr17:73836893..73836935,-p@chr17:73836893..73836935
-
Hg19::chr17:78945208..78945214,-p1@ENST00000545206
p1@uc002jyv.1
Hg19::chr19:14223454..14223463,-p9@PRKACA
Hg19::chr1:157801226..157801230,-p8@CD5L
Hg19::chr1:157801262..157801284,-p10@CD5L
Hg19::chr1:157811525..157811541,-p3@CD5L
Hg19::chr1:157811550..157811559,-p5@CD5L
Hg19::chr1:157811563..157811585,-p2@CD5L
Hg19::chr1:157811590..157811604,-p1@CD5L
Hg19::chr1:157811612..157811617,-p6@CD5L
Hg19::chr1:157811628..157811640,-p4@CD5L
Hg19::chr1:157811772..157811796,-p7@CD5L
Hg19::chr1:25890126..25890172,+p9@LDLRAP1
Hg19::chr21:28820892..28820899,-p4@ENST00000420186
p4@uc002ymh.2
Hg19::chr21:28820911..28820933,-p1@ENST00000420186
p1@uc002ymh.2
Hg19::chr21:28820941..28820952,-p2@ENST00000420186
p2@uc002ymh.2
Hg19::chr21:28820954..28820963,-p3@ENST00000420186
p3@uc002ymh.2
Hg19::chr21:40181520..40181558,+p11@ETS2
Hg19::chr21:40364741..40364783,-p@chr21:40364741..40364783
-
Hg19::chr22:36718586..36718593,-p@chr22:36718586..36718593
-
Hg19::chr2:1098240..1098249,+p3@SNTG2
Hg19::chr2:128321491..128321509,+p@chr2:128321491..128321509
+
Hg19::chr2:1418171..1418194,+p2@TPO
Hg19::chr2:1418195..1418210,+p6@TPO
Hg19::chr2:1507506..1507512,+p16@TPO
Hg19::chr2:1508349..1508357,+p@chr2:1508349..1508357
+
Hg19::chr2:1545753..1545760,-p@chr2:1545753..1545760
-
Hg19::chr2:218142645..218142648,+p@chr2:218142645..218142648
+
Hg19::chr2:218142682..218142730,+p@chr2:218142682..218142730
+
Hg19::chr2:218844734..218844743,-p@chr2:218844734..218844743
-
Hg19::chr2:218844745..218844765,-p@chr2:218844745..218844765
-
Hg19::chr3:119466528..119466536,+p4@C3orf15
Hg19::chr3:119466639..119466644,+p@chr3:119466639..119466644
+
Hg19::chr3:119466654..119466656,+p@chr3:119466654..119466656
+
Hg19::chr3:119466669..119466679,+p@chr3:119466669..119466679
+
Hg19::chr3:46505137..46505149,-p4@LTF
Hg19::chr3:46620614..46620623,+p8@TDGF1
Hg19::chr4:185269050..185269068,-p1@ENST00000511465
Hg19::chr4:186854504..186854528,-p34@SORBS2
Hg19::chr4:76901930..76901942,+p1@ENST00000501239
Hg19::chr5:1501865..1501869,-p@chr5:1501865..1501869
-
Hg19::chr5:1501872..1501883,-p@chr5:1501872..1501883
-
Hg19::chr5:1501941..1501953,-p@chr5:1501941..1501953
-
Hg19::chr5:152069112..152069147,-p1@ENST00000506723
p1@uc003luw.1
Hg19::chr5:76249436..76249479,+p2@CRHBP
Hg19::chr5:76249493..76249508,+p6@CRHBP
Hg19::chr6:36172477..36172497,+p@chr6:36172477..36172497
+
Hg19::chr6:56707958..56707979,-p44@DST
Hg19::chr7:100420483..100420489,-p12@EPHB4
Hg19::chr7:151070957..151070988,+p@chr7:151070957..151070988
+
Hg19::chr7:22259740..22259751,-p19@RAPGEF5
Hg19::chr7:84736120..84736124,-p@chr7:84736120..84736124
-
Hg19::chr8:22424709..22424716,-p2@ENST00000517384
Hg19::chr8:22424743..22424759,-p1@ENST00000517384
Hg19::chr8:22436248..22436259,+p11@PDLIM2
Hg19::chr8:47834174..47834213,+p1@ENST00000524012
Hg19::chr9:124516729..124516752,+p@chr9:124516729..124516752
+
Hg19::chr9:126579213..126579224,-p@chr9:126579213..126579224
-
Hg19::chr9:127260615..127260651,-p@chr9:127260615..127260651
-
Hg19::chr9:127263337..127263341,-p9@NR5A1
Hg19::chr9:127267367..127267383,+p@chr9:127267367..127267383
+
Hg19::chr9:127269434..127269438,-p8@NR5A1
Hg19::chr9:127269462..127269484,-p2@NR5A1
Hg19::chr9:127269488..127269495,-p5@NR5A1
Hg19::chr9:133973310..133973321,+p18@AIF1L
Hg19::chr9:133973327..133973338,+p17@AIF1L
Hg19::chr9:138596697..138596714,+p@chr9:138596697..138596714
+
Hg19::chr9:79223787..79223821,+p@chr9:79223787..79223821
+
Hg19::chr9:79894775..79894780,+p12@VPS13A
Hg19::chr9:79894790..79894797,+p10@VPS13A
Hg19::chrX:69645652..69645664,+p7@GDPD2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.